CVE-2022-26389

Published: Feb 7, 2025

Modified: Feb 7, 2025

PUBLISHED

CVSS v3.1

7.7

HIGH

Description

An improper access control vulnerability may allow privilege escalation.This issue affects: * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior; * ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph: Versions 2.3.1 and prior; * ELI 250c/BUR 250c Resting Electrocardiograph: Versions 2.1.2 and prior; * ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph: Versions 2.2.0 and prior.

Vendor	Product	Versions
Baxter/ Hillrom	ELI 380 Resting Electrocardiograph	affected `0 - <= 2.6.0`
Welch Allyn	ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph	affected `0 - <= 2.3.1`
Welch Allyn	ELI 250c/BUR 250c Resting Electrocardiograph	affected `0 - <= 2.1.2`
Welch Allyn	ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph	affected `0 - <= 2.2.0`

Weaknesses (CWE)

CWE-284

CVSS v3.1 Details

CVSS v3.1 Vector

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:L/A:H

Attack Vector

Network

Attack Complexity

High

Privileges Required

Low

User Interaction

None

Scope

Changed

Confidentiality

Low

Integrity

Low

Availability

High

References

https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-167-01

https://hillrom.com/en/responsible-disclosures/

Security Training

Train your team to recognize and prevent security threats with our comprehensive security awareness program.

Start Training

Vulnerability Scanning

Discover vulnerabilities in your applications and infrastructure before attackers do.

Scan Now

CVE-2022-26389

Description

Affected Products

Weaknesses (CWE)

CVSS v3.1 Details

References